IN8bio
INAB
21 hedge funds and large institutions have $2.58M invested in IN8bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
77% more capital inflows, than outflows
Capital inflows: $350K | Capital outflows: $198K
0.01% more ownership
Funds ownership: 7.83% → 7.84% (+0.01%)
5% less funds holding
Funds holding: 22 → 21 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Rock Creek Group
Washington,
District of Columbia
|
+$93.8K |
| 2 |
Voss Capital
Houston,
Texas
|
+$67.1K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64K |
| 4 |
Texas Capital Bank Wealth Management Services
Dallas,
Texas
|
+$53.1K |
| 5 |
Bridgeway Capital Management
Houston,
Texas
|
+$36.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$88.9K |
| 2 |
Renaissance Technologies
New York
|
-$33K |
| 3 |
Two Sigma Investments
New York
|
-$28K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$27.1K |
| 5 |
BlackRock
New York
|
-$19.2K |
INAB Hedge Fund Activity: Q3 2023 in Review
21 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q3 2023, worth a combined $2.58M — down 28% from $3.59M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of INAB and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 8 added.
The largest buyer was Rock Creek Group, adding an estimated $93.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $88.9K sold.
- 21 institutional investors held IN8bio (INAB) as of Q3 2023, down from 22 in Q2 2023.
- Funds reported $2.58M of IN8bio stock for Q3 2023, down 28% quarter-over-quarter.
- 3 funds opened new IN8bio positions in Q3 2023 and 4 closed out, a net change of -1 holder.
- The largest IN8bio buyer in Q3 2023 was Rock Creek Group, an estimated $93.8K added.
- The largest IN8bio seller in Q3 2023 was Citadel Advisors, an estimated $88.9K sold.
Based on aggregated 13F filings for Q3 2023.